{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T15:54:00Z","timestamp":1789746840719,"version":"4.0.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1992,10,1]],"date-time":"1992-10-01T00:00:00Z","timestamp":717897600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[1992,10]]},"DOI":"10.1007\/bf01703109","type":"journal-article","created":{"date-parts":[[2005,6,12]],"date-time":"2005-06-12T01:12:18Z","timestamp":1118538738000},"page":"162-168","source":"Crossref","is-referenced-by-count":114,"title":["The evaluation of low-dose cytarabine in the treatment of myelodysplastic syndromes: A phase-III intergroup study"],"prefix":"10.1007","volume":"65","author":[{"given":"K. B.","family":"Miller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Kyungmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. S.","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. N.","family":"Winter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. M.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. S.","family":"Neiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. R.","family":"Head","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. A.","family":"Cassileth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. J.","family":"O'Connell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF01703109_CR1","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1182\/blood.V72.2.705.705","volume":"72","author":"JH Antin","year":"1988","unstructured":"Antin JH, Smith BR, Holmes W, et al. (1988) Phase I\/II study of recombinant human granulocyte-macrophage colony-stimulating factor in aplastic anemia and myelodysplastic syndrome. Blood 72: 705\u2013713","journal-title":"Blood"},{"key":"BF01703109_CR2","doi-asserted-by":"crossref","first-page":"590","DOI":"10.7326\/0003-4819-112-8-590","volume":"11","author":"FR Appelbaum","year":"1990","unstructured":"Appelbaum FR, Barrall J, Storb R, et al. (1990) Bone marrow transplantation for patients with myelodysplasia. Ann Intern Med 11: 590\u2013597","journal-title":"Ann Intern Med"},{"key":"BF01703109_CR3","first-page":"601","volume":"65","author":"JO Armitage","year":"1981","unstructured":"Armitage JO, Dick FR, Needleman SW, et al. (1981) Effect of chemotherapy for the dysmyelopoietic syndrome. Cancer Treat Rep 65: 601\u2013605","journal-title":"Cancer Treat Rep"},{"key":"BF01703109_CR4","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2141.1982.tb08475.x","volume":"51","author":"JM Bennett","year":"1982","unstructured":"Bennett JM, Catovsky D, Daniel M-T, et al. (1982) Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 51: 189\u2013199","journal-title":"Br J Haematol"},{"key":"BF01703109_CR5","doi-asserted-by":"crossref","first-page":"620","DOI":"10.7326\/0003-4819-103-4-620","volume":"103","author":"JM Bennett","year":"1985","unstructured":"Bennett JM, Catovsky D, Daniel MT et al. (1985) Proposed revised criteris for the classification of acute myeloid leukemia: a report of the French-American-British Cooperative Group. Ann Intern Med 103: 620\u2013625","journal-title":"Ann Intern Med"},{"key":"BF01703109_CR6","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1200\/JCO.1986.4.12.1857","volume":"4","author":"BD Cheson","year":"1986","unstructured":"Cheson BD, Jasperse DM, Simon R, et al. (1986) A critical appraisal of low-dose cytosine arabinoside in patients with acute non-lymphocytic leukemia and myelodysplastic syndromes. J Clin Oncol 4: 1857\u20131864","journal-title":"J Clin Oncol"},{"key":"BF01703109_CR7","volume-title":"Analysis of binary data","author":"DR Cox","year":"1970","unstructured":"Cox DR (1970) Analysis of binary data. Champman and Hall, London"},{"key":"BF01703109_CR8","volume-title":"Analysis of survival data","author":"DR Cox","year":"1984","unstructured":"Cox DR, Oakes D (1984) Analysis of survival data. Champman and Hall, London"},{"key":"BF01703109_CR9","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF00320357","volume":"57","author":"P Fenaux","year":"1988","unstructured":"Fenaux P, Lai JL, Jounet JP, et al. (1988) Aggressive chemotherapy in adult primary myelodysplastic syndromes. Blut 57: 297\u2013302","journal-title":"Blut"},{"key":"BF01703109_CR10","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0145-2126(88)90144-0","volume":"12","author":"DW Galvani","year":"1988","unstructured":"Galvani DW, Nethersell ABW, Cawley JC (1988) \u03b1-interferon in myelodysplasia: clinical observations and effects on NK cell. Leuk Res 12: 257\u2013262","journal-title":"Leuk Res"},{"key":"BF01703109_CR11","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1182\/blood.V76.3.455.455","volume":"76","author":"A Ganser","year":"1990","unstructured":"Ganser A, Seipelt G, Lindermann A, et al. (1990) Effects of recombinant human interleukin-3 in patients with myelodysplastic syndromes. Blood 76: 455\u2013462","journal-title":"Blood"},{"key":"BF01703109_CR12","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/ajh.2830270303","volume":"27","author":"S Garcia","year":"1988","unstructured":"Garcia S, Sanz MA, Amigo V, et al. (1988) Prognostic factors in chronic myelodysplastic syndromes: a multivariate analysis in 107 cases. Am J Hematol 27: 163\u2013168","journal-title":"Am J Hematol"},{"key":"BF01703109_CR13","first-page":"744","volume":"10","author":"J Griffin","year":"1982","unstructured":"Griffin J, Munroe D, Major P (1982) Induction of differentiation of human myeloid leukemia cell by inhibitors of DNA synthesis. Exp Hematol 10: 744\u2013781","journal-title":"Exp Hematol"},{"key":"BF01703109_CR14","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier PP (1958) Nonparametric estimation from incomplete observations. J Am Statist Assoc 53: 457\u2013481","journal-title":"J Am Statist Assoc"},{"key":"BF01703109_CR15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2141.1987.tb06138.x","volume":"65","author":"H Kerhofs","year":"1987","unstructured":"Kerhofs H, Haak HL, Leeksma CHW (1987) Utility of the FAB classification for the myelodysplastic syndromes: investigation of prognostic factors in 237 cases. Br J Haematol 65: 73\u201381","journal-title":"Br J Haematol"},{"key":"BF01703109_CR16","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1182\/blood.V71.3.703.703","volume":"71","author":"HP Koeffler","year":"1988","unstructured":"Koeffler HP, Heitjan D, Mertelsmann R, et al. (1988) Randomized study of 13-cis retinoic acid vs placebo in the myelodys-plastic disorders. Blood 71: 703\u2013708","journal-title":"Blood"},{"key":"BF01703109_CR17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/biomet\/73.1.13","volume":"73","author":"KY Lang","year":"1986","unstructured":"Lang KY, Zeger SL (1986) Longitudinal data analysis using generalized linear models. Biometrika 73: 13\u201322","journal-title":"Biometrika"},{"key":"BF01703109_CR18","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1200\/JCO.1990.8.8.1424","volume":"8","author":"AF List","year":"1990","unstructured":"List AF, Garewal HS, Sandberg AA (1990) The myelodysplastic syndromes: biology and implications for management. J Clin Oncol 8: 1424\u20131441","journal-title":"J Clin Oncol"},{"key":"BF01703109_CR19","first-page":"167","volume":"50","author":"N Mantel","year":"1978","unstructured":"Mantel N (1978) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50: 167\u2013179","journal-title":"Cancer Chemother Rep"},{"key":"BF01703109_CR20","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/ajh.2830230207","volume":"23","author":"HD Priesler","year":"1986","unstructured":"Priesler HD, Raza A, Barcos M, et al. (1986) High-dose cytosine arabinoside in the treatment of preleukemic disorders: a Leukemia Intergroup study. Am J Hematol 23: 131\u2013138","journal-title":"Am J Hematol"},{"key":"BF01703109_CR21","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1365-2141.1986.tb07524.x","volume":"63","author":"G Tricot","year":"1986","unstructured":"Tricot G, Boogaerts MA (1986) The role of aggressive chemotherapy in the treatment of the myelodysplastic syndromes. Br J Haematol 63: 477\u2013483","journal-title":"Br J Haematol"},{"key":"BF01703109_CR22","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1056\/NEJM198712173172501","volume":"317","author":"S Vadhan-Raj","year":"1987","unstructured":"Vadhan-Raj S, Keating M, Le Maistre A, et al. (1987) Effects of recombinant human granulocyte-macrophage colony-stimulating factor in aplastic anemia and myelodysplastic syndromes. N Engl J Med 317: 1545\u20131552","journal-title":"N Engl J Med"},{"key":"BF01703109_CR23","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1600-0609.1988.tb00880.x","volume":"41","author":"M Weide Van der","year":"1988","unstructured":"Weide M Van der, Sizoo W, Nauta JJ, Krefft J, Langenhuijsen MM (1988) Myelodysplastic syndromes: analysis of clinical and prognostic features in 96 patients. Eur J Haematol 41: 115\u2013122","journal-title":"Eur J Haematol"},{"key":"BF01703109_CR24","first-page":"159","volume":"55","author":"DJ Weisdorf","year":"1981","unstructured":"Weisdorf DJ, Oken MM, Johnson GL, Rydell RE (1981) Chronic myelodysplastic syndrome. Short survival with or without evolution to acute leukemia. Br J Haematol 55: 159\u2013164","journal-title":"Br J Haematol"},{"key":"BF01703109_CR25","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/1097-0142(19850801)56:3<443::AID-CNCR2820560305>3.0.CO;2-Q","volume":"56","author":"JN Winter","year":"1985","unstructured":"Winter JN, Variakojis D, Gaynor ER (1985) Low-dose cytosine arabinoside (Ara-C) therapy in the myelodysplastic syndromes and acute leukemia. Cancer 56: 443\u2013449","journal-title":"Cancer"},{"key":"BF01703109_CR26","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1056\/NEJM198312293092602","volume":"309","author":"JS Wisch","year":"1983","unstructured":"Wisch JS, Griffin JD, Kyle DW (1983) Response of preleukemic syndromes to continuous infusion of low-dose cytarabine. N Engl J Med 309: 1599\u20131602","journal-title":"N Engl J Med"},{"key":"BF01703109_CR27","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1182\/blood.V67.6.1721.1721","volume":"67","author":"JJ Yunis","year":"1986","unstructured":"Yunis JJ, Rydell RE, Oken MM, Arnesen MA, Mayer MG, Lobell M (1986) Refined chromosome analysis as an independent prognostic indicator in de novo myelodysplastic syndromes. Blood 67: 1721\u20131730","journal-title":"Blood"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01703109.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01703109\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01703109","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T16:20:16Z","timestamp":1706286016000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01703109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,10]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1992,10]]}},"alternative-id":["BF01703109"],"URL":"https:\/\/doi.org\/10.1007\/bf01703109","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,10]]}}}